Taking into consideration the reality of 'vaccine nationalism' and the free-market principles by which pharmaceutical companies operate, is the COVAX facility the best deal Malaysia, and countries similar to us, can hope for, in terms of access to the vaccine. Melisa Idris and Sharaad Kuttan speak to Sangeeta Shashikant, Legal Advisor, Third World Network.
